TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ROYCE & ASSOCIATES LP | 18,339 | $163,951 | 0.00% |
Nuveen Asset Management, LLC | 705,303 | $6,305,408 | 0.00% |
Tower Research Capital LLC (TRC) | 7,929 | $70,886 | 0.00% |
Cutler Group LLC / CA | 2,700 | $24 | 0.00% |
BARCLAYS PLC | 288,654 | $2,579 | 0.00% |
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 55,806 | $499,000 | 0.00% |
FEDERATED HERMES, INC. | 97,491 | $871,570 | 0.00% |
NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 15,831 | $141,529 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 36,356 | $325,023 | 0.00% |
METROPOLITAN LIFE INSURANCE CO/NY | 4,440 | $39,694 | 0.00% |
Russell Investments Group, Ltd. | 97,513 | $871,765 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 1,440,644 | $12,880,945 | 0.00% |
STATE STREET CORP | 4,395,257 | $39,293,598 | 0.00% |
WOLVERINE ASSET MANAGEMENT LLC | 17,300 | $154,662 | 0.00% |
DEUTSCHE BANK AG\ | 308,456 | $2,757,597 | 0.00% |
CITIGROUP INC | 333,371 | $2,980,337 | 0.00% |
STATE OF WISCONSIN INVESTMENT BOARD | 54,363 | $486,005 | 0.00% |
MORGAN STANLEY | 2,240,337 | $20,028,613 | 0.00% |
Invesco Ltd. | 813,252 | $7,270,473 | 0.00% |
BlackRock Inc. | 7,633,205 | $68,240,853 | 0.00% |
External links
This page lists TRAVERE THERAPEUTICS INC's shareholders in Q3 2023. To view TRAVERE THERAPEUTICS INC's shareholder history, click here.